For purchasing or obtaining a quotation, please visit the Distributor page
to find your local distributor.
to find your local distributor.
HOME > Product search results
Searched by
Category - cancer
Product
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
MHC tetramer（280）
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M014-1 |
T-Select HLA-A*24:02 modified WT1 Tetramer-CYTWNQMNL-PE |
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| CYTWNQMNL | 235-243 | ４°C | ||||
|
|
TS-M546-1 |
H-2Db gp100 Tetramer-EGSRNQDWL-PE |
|
|||
|
|
cancer | PE | H-2Db | 50 tests | 10 or more | |
| EGSRNQDWL | 25-33 | ４°C | ||||
|
|
TS-M118-1 |
HLA-A*02:01 PRAME425-433 Tetramer-SLLQHLIGL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 10 or more | |
| SLLQHLIGL | 425-433 | ４°C | ||||
|
|
TS-M016-1 |
T-Select HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMFPNAPYL | 126-134 | ４°C | ||||
|
|
TS-M025-1 |
T-Select HLA-A*24:02 survivin-2B Tetramer-AYACNTSTL-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests | 1-9 | |
| AYACNTSTL | 80-88 | ４°C | ||||
|
|
TS-M505-1 |
T-Select H-2Db human gp100 Tetramer-KVPRNQDWL-PE |
|
|||
|
|
cancer | PE | H-2Db | 50 tests |
0 (Contact us) |
|
| KVPRNQDWL | 25-33 | ４°C | ||||
|
|
TS-M140-1 |
HLA-A*02:01 WT137-45 Tetramer-VLDFAPPGA-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 1-9 | |
| VLDFAPPGA | 37-45 | ４°C | ||||
|
|
TS-M085-1 |
HLA-A*02:01 Survivin (T2M) Tetramer-LMLGEFLKL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMLGEFLKL | 96-104 | ４°C | ||||
|
|
TS-M116-2 |
HLA-A*02:01 PRAME300-309 Tetramer-ALYVDSLFFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests | 1-9 | |
| ALYVDSLFFL | 300-309 | ４°C | ||||
|
|
TS-M011-2 |
HLA-A*02:01 NY-ESO-1 Tetramer-SLLMWITQC-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests | 1-9 | |
| SLLMWITQC | 157-165 | ４°C | ||||
|
|
TS-M118-2 |
HLA-A*02:01 PRAME425-433 Tetramer-SLLQHLIGL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLLQHLIGL | 425-433 | ４°C | ||||
|
|
TS-M011-1 |
HLA-A*02:01 NY-ESO-1 Tetramer-SLLMWITQC-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 10 or more | |
| SLLMWITQC | 157-165 | ４°C | ||||
|
|
TS-M504-1 |
T-Select H-2Db WT1 Tetramer-RMFPNAPYL-PE |
|
|||
|
|
cancer | PE | H-2Db | 50 tests | 1-9 | |
| RMFPNAPYL | 126-134 | ４°C | ||||
|
|
TS-5004-1C |
H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE |
|
|||
|
|
cancer | PE | H-2Kb | 50 tests | 1-9 | |
| SVYDFFVWL | 180-188 | ４°C | ||||
|
|
TS-0009-1C |
HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 1-9 | |
| ELAGIGILTV | 26-35 | ４°C | ||||
|
|
TS-M103-1 |
HLA-A*02:01 CEA Tetramer-YLSGANLNL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLSGANLNL | 605-613 | ４°C | ||||
|
|
TS-M117-1 |
HLA-A*02:01 PRAME100-108 Tetramer-VLDGLDVLL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 1-9 | |
| VLDGLDVLL | 100-108 | ４°C | ||||
|
|
TS-M504-2 |
T-Select H-2Db WT1126-134 Tetramer-RMFPNAPYL-APC |
|
|||
|
|
cancer | APC | H-2Db | 50 tests | 1-9 | |
| RMFPNAPYL | 126-134 | ４°C | ||||
|
|
TS-M116-1 |
HLA-A*02:01 PRAME300-309 Tetramer-ALYVDSLFFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYVDSLFFL | 300-309 | ４°C | ||||
|
|
TS-M085-2 |
HLA-A*02:01 Survivin (T2M) Tetramer-LMLGEFLKL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMLGEFLKL | 96-104 | ４°C | ||||
|
|
TS-M078-1 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 1-9 | |
| GLYDGMEHL | 254-262 | ４°C | ||||
|
|
TS-M558-1 |
H-2Kb MAGE-AX169-176 Tetramer-LGITYDGM-PE |
|
|||
|
|
cancer | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| LGITYDGM | 169-176 | ４°C | ||||
|
|
TS-M505-2 |
T-Select H-2Db human gp100 Tetramer-KVPRNQDWL-APC |
|
|||
|
|
cancer | APC | H-2Db | 50 tests | 1-9 | |
| KVPRNQDWL | 25-33 | ４°C | ||||
|
|
TS-M119-2 |
HLA-A*02:01 PRAME142-151 Tetramer-SLYSFPEPEA-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLYSFPEPEA | 142-151 | ４°C | ||||
|
|
TS-M561-1 |
H-2Db hPSA Tetramer-HCIRNKSVIL-PE |
|
|||
|
|
cancer | PE | H-2Db | 50 tests | 1-9 | |
| HCIRNKSVIL | 65-74 | ４°C | ||||
|
|
TS-M087-1 |
HLA-A*02:01 PSA Tetramer-KLQCVDLHV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 1-9 | |
| KLQCVDLHV | 146-154 | ４°C | ||||
|
|
TS-M140-2 |
HLA-A*02:01 WT137-45 Tetramer-VLDFAPPGA-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLDFAPPGA | 37-45 | ４°C | ||||
|
|
TS-M117-2 |
HLA-A*02:01 PRAME100-108 Tetramer-VLDGLDVLL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLDGLDVLL | 100-108 | ４°C | ||||
|
|
TS-M114-1 |
HLA-A*01:01 MAGE-A1 Tetramer-EADPTGHSY-PE |
|
|||
|
|
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| EADPTGHSY | 161-169 | ４°C | ||||
|
|
TS-M115-1 |
HLA-A*02:01 hTERT Tetramer-ILAKFLHWL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAKFLHWL | 540-548 | ４°C | ||||
|
|
TS-M119-1 |
HLA-A*02:01 PRAME142-151 Tetramer-SLYSFPEPEA-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLYSFPEPEA | 142-151 | ４°C | ||||
|
|
TS-M138-2 |
HLA-A*02:01 MAGE-C1 Tetramer-ILFGISLREV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILFGISLREV | 959-968 | ４°C | ||||
|
|
TS-M073-1 |
HLA-A*24:02 MAGE-A2 Tetramer-EYLQLVFGI-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| EYLQLVFGI | 156-164 | ４°C | ||||
|
|
TS-M071-1 |
HLA-B*07:02 MAGE-A1 Tetramer-RVRFFFPSL-PE |
|
|||
|
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| RVRFFFPSL | 289-297 | ４°C | ||||
|
|
TS-M010-1 |
T-Select HLA-A*24:02 hTERT Tetramer-VYGFVRACL-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests | 1-9 | |
| VYGFVRACL | 461-469 | ４°C | ||||
|
|
TS-M558-2 |
H-2Kb MAGE-AX169-176 Tetramer-LGITYDGM-APC |
|
|||
|
|
cancer | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| LGITYDGM | 169-176 | ４°C | ||||
|
|
TS-M563-1 |
H-2Kb pBM1 Tetramer-INFDFNTI-PE |
|
|||
|
|
cancer | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| INFDFNTI | 207-214 | ４°C | ||||
|
|
TS-M104-1 |
HLA-A*02:01 RHAMM Tetramer-ILSLELMKL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILSLELMKL | 165-173 | ４°C | ||||
|
|
TS-M025-2 |
T-Select HLA-A*24:02 survivin-2B Tetramer-AYACNTSTL-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| AYACNTSTL | 80-88 | ４°C | ||||
|
|
TS-M101-1 |
HLA-A*02:01 CD33 Tetramer-AIISGDSPV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| AIISGDSPV | 65-73 | ４°C | ||||
|
|
TS-M114-2 |
HLA-A*01:01 MAGE-A1 Tetramer-EADPTGHSY-APC |
|
|||
|
|
cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| EADPTGHSY | 161-169 | ４°C | ||||
|
|
TS-M559-2 |
H-2Kb MAGE-A5 Tetramer-HNTQYCNL-APC |
|
|||
|
|
cancer | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| HNTQYCNL | 5-12 | ４°C | ||||
|
|
TS-0019-1C |
T-Select HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMDGTMSQV | 368-376 | ４°C | ||||
|
|
TS-M090-2 |
HLA-A*24:02 tyrosinase Tetramer-AFLPWHRLF-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| AFLPWHRLF | 206-214 | ４°C | ||||
|
|
TS-M077-1 |
HLA-A*24:02 MAGE-A3 Tetramer-IMPKAGLLI-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| IMPKAGLLI | 195-203 | ４°C | ||||
|
|
TS-M138-1 |
HLA-A*02:01 MAGE-C1 Tetramer-ILFGISLREV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILFGISLREV | 959-968 | ４°C | ||||
|
|
TS-M087-2 |
HLA-A*02:01 PSA Tetramer-KLQCVDLHV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLQCVDLHV | 146-154 | ４°C | ||||
|
|
TS-M109-1 |
HLA-B*07:02 P2X5 Tetramer-TPNQRQNVC-PE |
|
|||
|
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| TPNQRQNVC | 110-118 | ４°C | ||||
|
|
TS-M080-1 |
HLA-A*02:01 CEA (N6D) Tetramer-YLSGADLNL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 1-9 | |
| YLSGADLNL | 605-613 | ４°C | ||||
|
|
TS-M561-2 |
H-2Db hPSA Tetramer-HCIRNKSVIL-APC |
|
|||
|
|
cancer | APC | H-2Db | 50 tests |
0 (Contact us) |
|
| HCIRNKSVIL | 65-74 | ４°C | ||||
|
|
TS-M137-1 |
HLA-A*01:01 AIM-2 Tetramer-RSDSGQQARY-PE |
|
|||
|
|
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| RSDSGQQARY | - | ４°C | ||||
|
|
TS-M104-2 |
HLA-A*02:01 RHAMM Tetramer-ILSLELMKL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILSLELMKL | 165-173 | ４°C | ||||
|
|
TS-M101-2 |
HLA-A*02:01 CD33 Tetramer-AIISGDSPV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AIISGDSPV | 65-73 | ４°C | ||||
|
|
TS-M090-1 |
HLA-A*24:02 tyrosinase Tetramer-AFLPWHRLF-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| AFLPWHRLF | 206-214 | ４°C | ||||
|
|
TS-M102-2 |
HLA-A*02:01 CD33 A65Y Tetramer-YIISGDSPV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YIISGDSPV | 65-73 | ４°C | ||||
|
|
TS-M109-2 |
HLA-B*07:02 P2X5 Tetramer-TPNQRQNVC-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| TPNQRQNVC | 110-118 | ４°C | ||||
|
|
TS-M089-1 |
HLA-A*24:02 gp100-intron 4 Tetramer-VYFFLPDHL-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests | 1-9 | |
| VYFFLPDHL | 170-178 | ４°C | ||||
|
|
TS-M115-2 |
HLA-A*02:01 hTERT Tetramer-ILAKFLHWL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAKFLHWL | 540-548 | ４°C | ||||
|
|
TS-M103-2 |
HLA-A*02:01 CEA Tetramer-YLSGANLNL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests | 1-9 | |
| YLSGANLNL | 605-613 | ４°C | ||||
|
|
TS-0019-2C |
T-Select HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests | 1-9 | |
| YMDGTMSQV | 368-376 | ４°C | ||||
|
|
TS-M102-1 |
HLA-A*02:01 CD33 A65Y Tetramer-YIISGDSPV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YIISGDSPV | 65-73 | ４°C | ||||
|
|
TS-M141-2 |
HLA-A*24:02 ACC-1 Tetramer-DYLQYVLQI-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| DYLQYVLQI | 15-23 | ４°C | ||||
|
|
TS-M137-2 |
HLA-A*01:01 AIM-2 Tetramer-RSDSGQQARY-APC |
|
|||
|
|
cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| RSDSGQQARY | - | ４°C | ||||
|
|
TS-M559-1 |
H-2Kb MAGE-A5 Tetramer-HNTQYCNL-PE |
|
|||
|
|
cancer | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| HNTQYCNL | 5-12 | ４°C | ||||
|
|
TS-M141-1 |
HLA-A*24:02 ACC-1 Tetramer-DYLQYVLQI-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| DYLQYVLQI | 15-23 | ４°C | ||||
|
|
TS-M080-2 |
HLA-A*02:01 CEA (N6D) Tetramer-YLSGADLNL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLSGADLNL | 605-613 | ４°C | ||||
|
|
TS-M563-2 |
H-2Kb pBM1 Tetramer-INFDFNTI-APC |
|
|||
|
|
cancer | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| INFDFNTI | 207-214 | ４°C | ||||
|
|
TS-0013-1C |
HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| IMDQVPFSV | 209-217 | ４°C | ||||
|
|
TS-0014-1C |
HLA-A*02:01 gp100 (Wild) Tetramer-ITDQVPFSV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ITDQVPFSV | 209-217 | ４°C | ||||
|
|
TS-5004-2C |
H-2Kb TRP-2 Tetramer-SVYDFFVWL-APC |
|
|||
|
|
cancer | APC | H-2Kb | 50 tests | 1-9 | |
| SVYDFFVWL | 180-188 | ４°C | ||||
|
|
TS-M095-1 |
HLA-A*02:01 PP2A Tetramer-SLLPAIVEL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLLPAIVEL | 402-410 | ４°C | ||||
|
|
TS-0009-2C |
HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ELAGIGILTV | 26-35 | ４°C | ||||
|
|
TS-0035-1C |
HLA-A*02:01 gp100 154-162 Tetramer-KTWGQYWQV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KTWGQYWQV | 154-162 | ４°C | ||||
|
|
TS-M120-1 |
HLA-A*02:01 PSA141-150 Tetramer-FLTPKKLQCV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLTPKKLQCV | 141-150 | ４°C | ||||
|
|
TS-M105-1 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 1-9 | |
| SLLMWITQV | 157-165 | ４°C | ||||
|
|
TS-M075-1 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVAELVHFL | 112-120 | ４°C | ||||
|
|
TS-0015-1C |
HLA-A*02:01 Her-2/neu Tetramer-KIFGSLAFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 1-9 | |
| KIFGSLAFL | 369-377 | ４°C | ||||
|
|
TS-M082-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | ４°C | ||||
|
|
TS-0013-2C |
HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests | 1-9 | |
| IMDQVPFSV | 209-217 | ４°C | ||||
|
|
TS-M074-1 |
HLA-A*01:01 MAGE-A3 Tetramer-EVDPIGHLY-PE |
|
|||
|
|
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| EVDPIGHLY | 168-176 | ４°C | ||||
|
|
TS-0014-2C |
HLA-A*02:01 gp100 (Wild) Tetramer-ITDQVPFSV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ITDQVPFSV | 209-217 | ４°C | ||||
|
|
TS-M076-1 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLWGPRALV | 271-279 | ４°C | ||||
|
|
TS-M070-1 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | ４°C | ||||
|
|
TS-M105-2 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests | 1-9 | |
| SLLMWITQV | 157-165 | ４°C | ||||
|
|
TS-0035-2C |
HLA-A*02:01 gp100 154-162 Tetramer-KTWGQYWQV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KTWGQYWQV | 154-162 | ４°C | ||||
|
|
TS-0015-2C |
HLA-A*02:01 Her-2/neu Tetramer-KIFGSLAFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KIFGSLAFL | 369-377 | ４°C | ||||
|
|
TS-M562-2 |
H-2Kb mTERT Tetramer-VGRNFTNL-APC |
|
|||
|
|
cancer | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| VGRNFTNL | 198-205 | ４°C | ||||
|
|
TS-0016-1 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLLQETELV | 689-697 | ４°C | ||||
|
|
TS-M107-2 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDVYNGLL | 299-307 | ４°C | ||||
|
|
TS-M562-1 |
H-2Kb mTERT Tetramer-VGRNFTNL-PE |
|
|||
|
|
cancer | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| VGRNFTNL | 198-205 | ４°C | ||||
|
|
TS-M088-1 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLLTVLTV | 12-20 | ４°C | ||||
|
|
TS-M120-2 |
HLA-A*02:01 PSA141-150 Tetramer-FLTPKKLQCV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLTPKKLQCV | 141-150 | ４°C | ||||
|
|
TS-M072-1 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | ４°C | ||||
|
|
TS-M107-1 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDVYNGLL | 299-307 | ４°C | ||||
|
|
TS-M088-2 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLLTVLTV | 12-20 | ４°C | ||||
|
|
TS-M014-2 |
T-Select HLA-A*24:02 modified WT1 Tetramer-CYTWNQMNL-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests | 1-9 | |
| CYTWNQMNL | 235-243 | ４°C | ||||
|
|
TS-M526-1 |
T-Select H-2Kd HER2 Tetramer-TYLPTNASL-PE |
|
|||
|
|
cancer | PE | H-2Kd | 50 tests | 1-9 | |
| TYLPTNASL | 63-71 | ４°C | ||||
|
|
TC-5113-1 |
H-2Db Adpgk Neoepitope Tetramer-ASMTNMELM-PE |
|
|||
|
|
cancer | PE | H-2Db | 50 tests |
0 (Contact us) |
|
| ASMTNMELM | ４°C | |||||
|
|
TS-TCR01-1 |
Human TCR Tetramer-PE (HLA-A*24:02 survivin-2B80-88-AYACNTSTL) |
|
|||
|
|
cancer | PE | 50 tests |
0 (Contact us) |
||
| ４°C | ||||||
|
|
TS-M546-2 |
H-2Db gp100 Tetramer-EGSRNQDWL-APC |
|
|||
|
|
cancer | APC | H-2Db | 50 tests |
0 (Contact us) |
|
| EGSRNQDWL | 25-33 | ４°C | ||||
- The availability is based on the information in Japan at 17:00, Nov 12, 2025 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.